240 related articles for article (PubMed ID: 35875798)
1. Longitudinal Intraindividual Cognitive Variability Is Associated With Reduction in Regional Cerebral Blood Flow Among Alzheimer's Disease Biomarker-Positive Older Adults.
Holmqvist SL; Thomas KR; Brenner EK; Edmonds EC; Calcetas A; Edwards L; Bordyug M; Bangen KJ
Front Aging Neurosci; 2022; 14():859873. PubMed ID: 35875798
[TBL] [Abstract][Full Text] [Related]
2. Cognitive dispersion is elevated in amyloid-positive older adults and associated with regional hypoperfusion.
Holmqvist SL; Thomas KR; Edmonds EC; Calcetas A; Edwards L; Bangen KJ;
J Int Neuropsychol Soc; 2023 Aug; 29(7):621-631. PubMed ID: 36093903
[TBL] [Abstract][Full Text] [Related]
3. Regional Hypoperfusion Predicts Decline in Everyday Functioning at Three-Year Follow-Up in Older Adults without Dementia.
Sanchez DL; Thomas KR; Edmonds EC; Bondi MW; Bangen KJ;
J Alzheimers Dis; 2020; 77(3):1291-1304. PubMed ID: 32831202
[TBL] [Abstract][Full Text] [Related]
4. Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults.
Bangen KJ; Thomas KR; Sanchez DL; Edmonds EC; Weigand AJ; Delano-Wood L; Bondi MW;
J Alzheimers Dis; 2021; 81(4):1711-1725. PubMed ID: 33967041
[TBL] [Abstract][Full Text] [Related]
5. Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults.
Bangen KJ; Weigand AJ; Thomas KR; Delano-Wood L; Clark LR; Eppig J; Werhane ML; Edmonds EC; Bondi MW
Neuropsychology; 2019 Jul; 33(5):599-608. PubMed ID: 30896235
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults.
Bangen KJ; Clark AL; Edmonds EC; Evangelista ND; Werhane ML; Thomas KR; Locano LE; Tran M; Zlatar ZZ; Nation DA; Bondi MW; Delano-Wood L
Front Aging Neurosci; 2017; 9():181. PubMed ID: 28642699
[TBL] [Abstract][Full Text] [Related]
7. Reduced Regional Cerebral Blood Flow Relates to Poorer Cognition in Older Adults With Type 2 Diabetes.
Bangen KJ; Werhane ML; Weigand AJ; Edmonds EC; Delano-Wood L; Thomas KR; Nation DA; Evangelista ND; Clark AL; Liu TT; Bondi MW
Front Aging Neurosci; 2018; 10():270. PubMed ID: 30250430
[TBL] [Abstract][Full Text] [Related]
8. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Yew B; Nation DA;
Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
[TBL] [Abstract][Full Text] [Related]
9. Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.
Dickerson BC; Wolk DA;
Front Aging Neurosci; 2013; 5():55. PubMed ID: 24130528
[TBL] [Abstract][Full Text] [Related]
10. Intraindividual variability in neuropsychological performance predicts longitudinal cortical volume loss in early Parkinson's disease.
Jones JD; Valenzuela YG; Uribe C; Bunch J; Kuhn TP
Neuropsychology; 2022 Sep; 36(6):513-519. PubMed ID: 35377683
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.
Camargo A; Wang Z;
J Alzheimers Dis; 2021; 81(4):1727-1735. PubMed ID: 33967053
[TBL] [Abstract][Full Text] [Related]
12. Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum.
Chen YH; Lin RR; Huang HF; Xue YY; Tao QQ
Front Aging Neurosci; 2022; 14():848180. PubMed ID: 35847667
[TBL] [Abstract][Full Text] [Related]
13. Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease.
Nabizadeh F; Balabandian M; Rostami MR; Mehrabi S; Sedighi M;
Neurol Lett; 2023 Apr; 2(1):16-24. PubMed ID: 38327487
[TBL] [Abstract][Full Text] [Related]
14. Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.
Wierenga CE; Hays CC; Zlatar ZZ
J Alzheimers Dis; 2014; 42 Suppl 4(Suppl 4):S411-9. PubMed ID: 25159672
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
[TBL] [Abstract][Full Text] [Related]
16. The structural MRI markers and cognitive decline in prodromal Alzheimer's disease: a 2-year longitudinal study.
Wei H; Kong M; Zhang C; Guan L; Ba M;
Quant Imaging Med Surg; 2018 Nov; 8(10):1004-1019. PubMed ID: 30598878
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Cerebral Perfusion on Arterial Spin Labeling (ASL) MRI with Brain Volumetry and Cognitive Performance in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease.
Soman S; Raghavan S; Rajesh PG; Varma RP; Mohanan N; Ramachandran SS; Thomas B; Kesavadas C; Menon RN
Ann Indian Acad Neurol; 2021; 24(4):559-565. PubMed ID: 34728951
[TBL] [Abstract][Full Text] [Related]
18. Intrusion errors moderate the relationship between blood glucose and regional cerebral blood flow in cognitively unimpaired older adults.
Thomas KR; Weigand AJ; Cota IH; Edmonds EC; Wierenga CE; Bondi MW; Bangen KJ;
Brain Imaging Behav; 2022 Feb; 16(1):219-227. PubMed ID: 34415491
[TBL] [Abstract][Full Text] [Related]
19. Mild Cognitive Impairment Staging Yields Genetic Susceptibility, Biomarker, and Neuroimaging Differences.
Moore EE; Liu D; Pechman KR; Acosta LMY; Bell SP; Davis LT; Blennow K; Zetterberg H; Landman BA; Schrag MS; Hohman TJ; Gifford KA; Jefferson AL
Front Aging Neurosci; 2020; 12():139. PubMed ID: 32581762
[TBL] [Abstract][Full Text] [Related]
20. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
